Neurostimulation Devices Market

Industry Overview

The global neurostimulation devices market is predicted to grow at 12.6% CAGR during the forecast period with the market size reaching USD 16.2 billion by 2030. Neurostimulation is the technology to deliver low voltage electricity to a specific nerve or target in the spinal cord or brain to affect neuronal transmission. It is a therapeutic tool used to treat neuropathic pain or to modulate motor function and for a range of different diseases such as epilepsy, migraine, and Parkinson’s disease. The global neurostimulation devices market is growing at significant rate due to increasing prevalence of neurological diseases and growing geriatric population. The market has witnessed high demand for internal neurostimulation over the last few years, due to the increasing prevalence of neurological disorders.

Market Segmentation

Insight by Product

There are two types of neurostimulation devices, internal and external. Of both, internal neurostimulation device market accounted for the major share in the global market, due to the increasing prevalence of the neurological disorder. The internal neurostimulation segment is further segmented into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, cochear implant and gastric electrical stimulation. Spinal cord stimulation segment is estimated to account the largest share in the internal neurostimulation device market due to increasing awareness of spinal cord stimulator and increasing number of people suffering from chronic leg and back pain. The external neurostimulation segment is segmented into transcranial magnetic stimulation and transcranial electric nerve stimulation.

Insight by Application

The different applications of neurostimulation devices are pain management, essential tremor, Parkinson’s disease, urinary and fecal incontinence, depression, epilepsy, gastroparesis, hearing loss, dystonia and others. The pain management segment is estimated to account the largest share in the neurostimulation device market due to the increasing number of product launches and approvals of devices to reduce chronic pain. In addition, the epilepsy segment is expected to grow at the fastest rate due to the availability of new therapeutic procedures. According to the World Health Organization (WHO), globally approximately 50 million people have epilepsy and approximately 2.4 million people are diagnosed with epilepsy each year.

Global Neurostimulation Devices Market Report Coverage

Report Metric	Details
Historical Period	2018–2022
Base Year Considered	2022
Forecast Period	2023 - 2030
Market Size in 2022	$xx.x Billion
Revenue Forecast in 2030	$16.2 Billion
Growth Rate	CAGR 12.6%
Segments Covered in the Report	By Product and By Application
Report Scope	Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report	North America, Europe, Asia-Pacific, Middle East, and Rest of the World

Industry Dynamics

Growth Drivers

The growing prevalence of neurological disorders, increasing prevalence of lifestyle-associated diseases, robust product pipeline and mounting geriatric population are the primary growth drivers for the neurostimulation device market. Neuromodulation devices have shown to be very effective in treating Parkinson’s and other chronic illnesses induced by old age. According to the WHO, globally depression is a common mental disorder and approximately 300 million people of all age groups suffer from depression. Expanded target applications and new indications, increasing healthcare expenditure, increasing demand for minimally invasive surgeries, and increasing adoption of technologically advanced products are also fueling the growth of the neurostimulation devices market.

Increasing Prevalence of Neurological Disorders: Neurological disorders such as chronic pain, Parkinson's disease, epilepsy, and depression are becoming more prevalent globally. As the incidence of these conditions rises, the demand for neurostimulation devices as a treatment option also increases.

Growing Aging Population: The world's population is aging, leading to a higher prevalence of age-related neurological disorders. Neurostimulation devices offer a viable treatment option for elderly patients who may have limited tolerance for medications or are unresponsive to traditional therapies.

Patient Preference for Non-Pharmacological Treatment: Many patients prefer non-pharmacological treatment options due to concerns about potential side effects or addiction to medications. Neurostimulation devices offer an alternative approach to managing chronic pain and neurological disorders, providing patients with the opportunity to reduce reliance on medications.

Increasing Awareness and Acceptance: There has been a significant increase in public awareness about neurostimulation devices and their potential benefits. As more patients and healthcare professionals become aware of the therapeutic options available, there is greater acceptance and adoption of neurostimulation devices.

Challenges

The lack of trained professionals and unfavorable reimbursement scenarios are the major challenges to the growth of the neurostimulation device market. In addition, the availability of alternative options of treatment for neurological disorders and side effects and risks associated with neurostimulation therapy are also some of the factors hindering the growth of the market.

Neurostimulation devices may not be equally effective for all patients. Response variability exists, and it can be challenging to predict which patients will respond positively to neurostimulation therapy. Improving patient selection criteria and developing personalized treatment approaches are areas that require further research and development.

Industry Ecosystem

The key challenge for the new entrants is survival in capital intensive and highly regulated neurostimulation device market. However, various large neurostimulation companies can enter the neurostimulation device market through mergers and acquisitions of smaller companies.

Geographic Overview

Geographically, North America is the largest neurostimulation devices market as the region has a high prevalence of chronic diseases and a growing geriatric population. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015 approximately 23.1 million people in the U.S. had diabetes. In addition according to the National Institutes of Health, in the U.S. approximately one million people have Parkinson’s disease. As per the Alzheimer's Association in 2017, 5.5 million Americans had Alzheimer and about 5.3 million of this patient population’s age was 65 years or more. In addition, according to Alzheimer's Association, approximately 14 million people are expected to suffer from Alzheimer's in 2050.

Asia-Pacific is observed to witness the fastest growth in the market. The largest population, increasing prevalence of diabetes, growing geriatric population, and rising adoption of neurostimulation devices is creating a positive impact on the neurostimulation device market growth in the region.   

Competitive Insight

Key players in the neurostimulation device industry are investing in the development of innovative and advanced neurostimulation device products, which is strengthening their position in the market.  In September 2017, Medtronic, Inc. received FDA approval and launched the Intellis platform for the management of certain types of chronic intractable pain. Medtronic, Inc., Boston Scientific Corporation, Cyberonics, Inc., Nevro Corporation, Neurosigma, Inc., Neuropace, Inc., Cochlear Ltd., St. Jude Medical Inc., LivaNova PLC, Aleva Neurotherapeutics SA, Synapse Biomedical, Inc., Neuronetics, Inc. are some of the key players offering neurostimulation devices.

The Neurostimulation Devices Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2023–2030.

• By Product
  • Implantable/Internal Neurostimulation Device
    •  Spinal Cord Stimulators
    •  Deep Brain Stimulators
    •  Sacral Nerve Stimulators
    •  Gastric Electric Stimulators
    •  Vagus Nerve Stimulators
    •  Cochlear Implants
  • External Neurostimulation Device
    •  Transcutaneous Electrical Nerve Stimulators
    •  Transcranial Magnetic Stimulators
• By Application
  • Dystonia
  • Pain Management
  • Depression
  • Epilepsy
  • Gastroparesis
  • Parkinson's Disease
  • Essential Tremor
  • Urinary & Fecal Incontinence
  • Others

Neurostimulation Devices Market by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Indonesia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Rest of MEA

 

Source: VynZ Research

1. Research Overview

1.1. The Report Offers

1.2. Market Coverage

1.2.1. By Product

1.2.2. By Application

1.2.3. By Region

1.3. Research Phases

1.4. Limitations

1.5. Market Size Estimations and Forecast

1.5.1. Data Sources

1.5.1.1. Primary Research

1.5.1.2. Secondary Research

1.5.2. Methodology

1.5.2.1. Data Exploration

1.5.2.2. Forecast Parameters

1.5.2.3. Data Validation

1.5.2.4. Assumptions

1.5.3. Study Period & Data Reporting Unit

2. Executive Summary

3. Market Definition

3.1. By Product

3.1.1. Implantable/Internal Neurostimulation Device

3.1.1.1. Spinal Cord Stimulators

3.1.1.2. Deep Brain Stimulators

3.1.1.3. Sacral Nerve Stimulators

3.1.1.4. Gastric Electric Stimulators

3.1.1.5. Vagus Nerve Stimulators

3.1.1.6. Cochlear Implants

3.1.2. External Neurostimulation Device

3.1.2.1. Transcutaneous Electrical Nerve Stimulators

3.1.2.2. Transcranial Magnetic Stimulators

3.2. By Application

3.2.1. Dystonia

3.2.2. Pain Management

3.2.3. Depression

3.2.4. Epilepsy

3.2.5. Gastroparesis

3.2.6. Parkinson’s Disease

3.2.7. Essential Tremor

3.2.8. Urinary & Fecal Incontinence

3.2.9. Others

4. Industry Overview

4.1. Industry Dynamics

4.1.1. Major Drivers

4.1.2. Major Restraints

4.1.3. Key Trends

4.1.4. Key Opportunities

4.2. Industry Ecosystem

4.2.1. Porter’s Five Forces Analysis

4.2.2. Value Chain Analysis

4.2.3. Regulatory Framework

4.3. Competitive Insight

4.3.1. Company Share Analysis

4.3.2. Market Attractive Analysis

5. Global Market Estimate and Forecast

5.1. By Product

5.2. By Application

5.3. By Region

6. North America Market Estimate and Forecast

6.1. By Product

6.2. By Application

6.3. By Country

6.3.1. U.S. Market Estimate and Forecast

6.3.1.1. By Product

6.3.1.2. By Application

6.3.2. Canada Market Estimate and Forecast

6.3.2.1. By Product

6.3.2.2. By Application

7. Europe Market Estimate and Forecast

7.1. By Product

7.2. By Application

7.3. By Country

7.3.1. Germany Market Estimate and Forecast

7.3.1.1. By Product

7.3.1.2. By Application

7.3.2. U.K. Market Estimate and Forecast

7.3.2.1. By Product

7.3.2.2. By Application

7.3.3. France Market Estimate and Forecast

7.3.3.1. By Product

7.3.3.2. By Application

7.3.4. Italy Market Estimate and Forecast

7.3.4.1. By Product

7.3.4.2. By Application

7.3.5. Spain Market Estimate and Forecast

7.3.5.1. By Product

7.3.5.2. By Application

7.3.6. Rest of Europe Market Estimate and Forecast

7.3.6.1. By Product

7.3.6.2. By Application

8. Asia-Pacific Market Estimate and Forecast

8.1. By Product

8.2. By Application

8.3. By Country

8.3.1. Japan Market Estimate and Forecast

8.3.1.1. By Product

8.3.1.2. By Application

8.3.2. China Market Estimate and Forecast

8.3.2.1. By Product

8.3.2.2. By Application

8.3.3. India Market Estimate and Forecast

8.3.3.1. By Product

8.3.3.2. By Application

8.3.4. Australia Market Estimate and Forecast

8.3.4.1. By Product

8.3.4.2. By Application

8.3.5. South Korea Market Estimate and Forecast

8.3.5.1. By Product

8.3.5.2. By Application

8.3.6. Indonesia Market Estimate and Forecast

8.3.6.1. By Product

8.3.6.2. By Application

8.3.7. Rest of Asia-Pacific Market Estimate and Forecast

8.3.7.1. By Product

8.3.7.2. By Application

9. Latin America Market Estimate and Forecast

9.1. By Product

9.2. By Application

9.3. By Country

9.3.1. Brazil Market Estimate and Forecast

9.3.1.1. By Product

9.3.1.2. By Application

9.3.2. Mexico Market Estimate and Forecast

9.3.2.1. By Product

9.3.2.2. By Application

9.3.3. Rest of Latin America Market Estimate and Forecast

9.3.3.1. By Product

9.3.3.2. By Application

10.  Middle East & Africa (MEA) Market Estimate and Forecast

10.1. By Product

10.2. By Application

10.3. By Country

10.3.1.  South Africa Market Estimate and Forecast

10.3.1.1. By Product

10.3.1.2. By Application

10.3.2.  Saudi Arabia Market Estimate and Forecast

10.3.2.1. By Product

10.3.2.2. By Application

10.3.3.  Rest of MEA Market Estimate and Forecast

10.3.3.1. By Product

10.3.3.2. By Application

11.  Company Profiles

11.1. Medtronic plc

11.1.1.  Snapshot

11.1.2.  Overview

11.1.3.  Offerings

11.1.4.  Financial Insight

11.1.5.  Recent Developments

11.2. Boston Scientific Corporation

11.2.1.  Snapshot

11.2.2.  Overview

11.2.3.  Offerings

11.2.4.  Financial Insight

11.2.5.  Recent Developments

11.3. Bayer Corporation

11.3.1.  Snapshot

11.3.2.  Overview

11.3.3.  Offerings

11.3.4.  Financial Insight

11.3.5.  Recent Developments

11.4. Cyberonics, Inc.

11.4.1.  Snapshot

11.4.2.  Overview

11.4.3.  Offerings

11.4.4.  Financial Insight

11.4.5.  Recent Developments

11.5. Interpace, Inc.

11.5.1.  Snapshot

11.5.2.  Overview

11.5.3.  Offerings

11.5.4.  Financial Insight

11.5.5.  Recent Developments

11.6. Nevro Corporation

11.6.1.  Snapshot

11.6.2.  Overview

11.6.3.  Offerings

11.6.4.  Financial Insight

11.6.5.  Recent Developments

11.7. Neurosigma, Inc.

11.7.1.  Snapshot

11.7.2.  Overview

11.7.3.  Offerings

11.7.4.  Financial Insight

11.7.5.  Recent Developments

11.8. Neuropace, Inc.

11.8.1.  Snapshot

11.8.2.  Overview

11.8.3.  Offerings

11.8.4.  Financial Insight

11.8.5.  Recent Developments

11.9. Synapse Biomedical, Inc

11.9.1.  Snapshot

11.9.2.  Overview

11.9.3.  Offerings

11.9.4.  Financial Insight

11.9.5.  Recent Developments

11.10. ImThera Medical Inc.

11.10.1. Snapshot

11.10.2. Overview

11.10.3. Offerings

11.10.4. Financial Insight

11.10.5. Recent Developments

11.11. Neuronetics, Inc.

11.11.1. Snapshot

11.11.2. Overview

11.11.3. Offerings

11.11.4. Financial Insight

11.11.5. Recent Developments

11.12. Aleva Neurotherapeutics SA

11.12.1. Snapshot

11.12.2. Overview

11.12.3. Offerings

11.12.4. Financial Insight

11.12.5. Recent Developments

11.13. St. Jude Medical Inc.

11.13.1. Snapshot

11.13.2. Overview

11.13.3. Offerings

11.13.4. Financial Insight

11.13.5. Recent Developments

11.14. LivaNova

11.14.1. Snapshot

11.14.2. Overview

11.14.3. Offerings

11.14.4. Financial Insight

11.14.5. Recent Developments

11.15. Cochlear Ltd.

11.15.1. Snapshot

11.15.2. Overview

11.15.3. Offerings

11.15.4. Financial Insight

11.15.5. Recent Developments

* Financial insight, are subject to availability of information in the secondary domain.

List of Tables

Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 5 Global Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 6 Global Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 7 Global Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 8 Global Neurostimulation Device Market Size, by Region, 2018 – 2022 (USD Billion)
Table 9 Global Neurostimulation Device Market Size, by Region, 2023 - 2030 (USD Billion)
Table 10 North America Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 11 North America Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 12 North America Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 13 North America Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 14 North America Neurostimulation Device Market Size, by Country, 2018 – 2022 (USD Billion)
Table 15 North America Neurostimulation Device Market Size, by Country, 2023 - 2030 (USD Billion)
Table 16 U.S. Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 17 U.S. Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 18 U.S. Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 19 U.S. Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 20 Canada Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 21 Canada Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 22 Canada Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 23 Canada Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 24 Europe Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 25 Europe Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 26 Europe Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 27 Europe Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 28 Europe Neurostimulation Device Market Size, by Country, 2018 – 2022 (USD Billion)
Table 29 Europe Neurostimulation Device Market Size, by Country, 2023 - 2030 (USD Billion)
Table 30 Germany Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 31 Germany Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 32 Germany Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 33 Germany Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 34 U.K. Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 35 U.K. Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 36 U.K. Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 37 U.K. Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 38 France Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 39 France Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 40 France Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 41 France Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 42 Italy Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 43 Italy Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 44 Italy Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 45 Italy Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 46 RoE Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 47 RoE Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 48 RoE Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 49 RoE Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Million
Table 50 Asia-Pacific Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 51 Asia-Pacific Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 52 Asia-Pacific Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 53 Asia-Pacific Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 54 Asia-Pacific Neurostimulation Device Market Size, by Country, 2018 – 2022 (USD Billion)
Table 55 Asia-Pacific Neurostimulation Device Market Size, by Country, 2023 - 2030 (USD Billion)
Table 56 Japan Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 57 Japan Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 58 Japan Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 59 Japan Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 60 China Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 61 China Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 62 China Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 63 China Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 64 India Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 65 India Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 66 India Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 67 India Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 68 Australia Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 69 Australia Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 70 Australia Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 71 Australia Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 72 Indonesia Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 73 Indonesia Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 74 Indonesia Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 75 Indonesia Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 76 Rest of Asia-Pacific Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 77 Rest of Asia-Pacific Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 78 Rest of Asia-Pacific Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 79 Rest of Asia-Pacific Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 80 Latin America Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 81 Latin America Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 82 Latin America Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 83 Latin America Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 84 Latin America Neurostimulation Device Market Size, by Country, 2018 – 2022 (USD Billion)
Table 85 Latin America Neurostimulation Device Market Size, by Country, 2023 - 2030 (USD Billion)
Table 86 Brazil Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 87 Brazil Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 88 Brazil Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 89 Brazil Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 90 Mexico Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 91 Mexico Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 92 Mexico Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 93 Mexico Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 94 Rest of Latin America Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 95 Rest of Latin America Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 96 Rest of Latin America Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 97 Rest of Latin America Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 98 MEA Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 99 MEA Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 100 MEA Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 101 MEA Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 102 MEA Neurostimulation Device Market Size, by Country, 2018 – 2022 (USD Billion)
Table 103 MEA Neurostimulation Device Market Size, by Country, 2023 - 2030 (USD Billion)
Table 104 South Africa Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table105 South Africa Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 106 South Africa Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 107 South Africa Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 108 Saudi Arabia Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table109 Saudi Arabia Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 110 Saudi Arabia Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 111 Saudi Arabia Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 112 Rest of MEA Neurostimulation Device Market Size, by Product, 2018 – 2022 (USD Billion)
Table 113 Rest of MEA Neurostimulation Device Market Size, by Product, 2023 - 2030 (USD Billion)
Table 114 Rest of MEA Neurostimulation Device Market Size, by Application, 2018 – 2022 (USD Billion)
Table 115 Rest of MEA Neurostimulation Device Market Size, by Application, 2023 - 2030 (USD Billion)
Table 116 Snapshot – Medtronic plc
Table 117 Snapshot – Boston Scientific Corporation
Table 118 Snapshot – Bayer Corporation
Table 119 Snapshot – Cyberonics, Inc.
Table 120 Snapshot – Interpace, Inc.
Table 121 Snapshot – Nevro Corporation
Table 122 Snapshot – Neurosigma, Inc.
Table 123 Snapshot – Neuropace, Inc.
Table 124 Snapshot – Synapse Biomedical, Inc
Table 125 Snapshot – ImThera Medical Inc.
Table 126 Snapshot – Neuronetics, Inc.
Table 127 Snapshot – Aleva Neurotherapeutics SA
Table 128 Snapshot – St. Jude Medical Inc.
Table 129 Snapshot – LivaNova PLC
Table 130 Snapshot – Cochlear Ltd.

List of Figures

Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Sources for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global Neurostimulation Device Market - Growth Drivers and Restraints
Figure 10 Product Benchmark
Figure 11 Global Neurostimulation Device Market Highlight
Figure 12 Global Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 14 Global Neurostimulation Device Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 15 North America Neurostimulation Device Market Highlight
Figure 16 North America Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 18 North America Neurostimulation Device Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 19 U.S. Neurostimulation Device Market Highlight
Figure 20 U.S. Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 22 Canada Neurostimulation Device Market Highlight
Figure 23 Canada Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 25 Europe Neurostimulation Device Market Highlight
Figure 26 Europe Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 28 Europe Neurostimulation Device Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 29 Germany Neurostimulation Device Market Highlight
Figure 30 Germany Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 31 Germany Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 32 U.K. Neurostimulation Device Market Highlight
Figure 33 U.K. Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Million
Figure 34 U.K. Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 35 France Neurostimulation Device Market Highlight
Figure 36 France Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 37 France Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 38 Italy Neurostimulation Device Market Highlight
Figure 39 Italy Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 40 Italy Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 41 Rest of Europe Neurostimulation Device Market Highlight
Figure 42 Rest of Europe Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 43 Rest of Europe Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 44 Asia-Pacific Neurostimulation Device Market Highlight
Figure 45 Asia-Pacific Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 46 Asia-Pacific Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 47 Asia-Pacific Neurostimulation Device Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 48 Japan Neurostimulation Device Market Highlight
Figure 49 Japan Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 50 Japan Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 51 China Neurostimulation Device Market Highlight
Figure 52 China Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 53 China Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 54 India Neurostimulation Device Market Highlight
Figure 55 India Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 56 India Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 57 Australia Neurostimulation Device Market Highlight
Figure 58 Australia Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 59 Australia Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 60 Indonesia Neurostimulation Device Market Highlight
Figure 61 Indonesia Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 62 Indonesia Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 63 Rest of Asia-Pacific Neurostimulation Device Market Highlight
Figure 64 Rest of Asia-Pacific Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 65 Rest of Asia-Pacific Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 66 Latin America Neurostimulation Device Market Highlight
Figure 67 Latin America Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 68 Latin America Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 69 Latin America Neurostimulation Device Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 70 Brazil Neurostimulation Device Market Highlight
Figure 71 Brazil Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 72 Brazil Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 73 Mexico Neurostimulation Device Market Highlight
Figure 74 Mexico Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 75 Mexico Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 76 Rest of Latin America Neurostimulation Device Market Highlight
Figure 77 Rest of Latin America Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 78 Rest of Latin America Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 79 MEA Neurostimulation Device Market Highlight
Figure 80 MEA Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 81 MEA Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 82 MEA Neurostimulation Device Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 83 Saudi Arabia Neurostimulation Device Market Highlight
Figure 84 Saudi Arabia Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 85 Saudi Arabia Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 86 South Africa Neurostimulation Device Market Highlight
Figure 87 South Africa Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 88 South Africa Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 89 Rest of MEA Neurostimulation Device Market Highlight
Figure 90 Rest of MEA Neurostimulation Device Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 91 Rest of MEA Neurostimulation Device Market Size, by Application, 2018 - 2030 (USD Billion)